Stay updated on ED-SCLC Immuno-Therapy Clinical Trial
Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page
- Check2 days agoChange DetectedRemoved a MedlinePlus Genetics topic on Lung cancer, reducing genetics content coverage on that disease.SummaryDifference0.1%
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference2%
- Check24 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.3%
- Check38 days agoChange Detected- Revision updated to v3.0.2, replacing v3.0.1. - The 'Back to Top' link was removed.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check52 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous locations and related topics, while also removing several previously listed locations and topics. Notably, the facility name and various geographic locations have been added, enhancing the page's content related to drug safety and lung cancer.SummaryDifference16%
Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.